Arthritis & Degenerative Disease
Department of Entomology & UCD Comprehensive Cancer Center
Director, NIEHS-UCD Superfund Research Program
PI, NIH Biotechnology Training Program
(See also: Anesthesia/Pain Managment, Dentistry/Oral Biology, Food Animal Medicine, Pharmacology)
Dr. Hammock’s laboratory has a long collaboration with faculty and students in the school of veterinary medicine. His laboratory develops mass spectral and biosensor analytical methods for environmental contaminants and drugs in companion animals. The laboratory is working on a new branch of the arachidonic acid cascade and is developing drugs to block arthritic and laminitic inflammation in horses and inflammatory and post surgical pain in dogs and cats associated with injury, diabetes, age and other criteria.
Use of inhibitors of the soluble epoxide hydrolase to potential treat disease in companion animals such as dogs and cats as well as horses and livestock species.
Pharmacokinetic analysis in development of novel pharmaceuticals for veterinary use.
Fundamental mechanism of action of regulatory lipids.
Natural food additives to expand the efficacy of omega 3 fatty acid supplements in food of companion animal and livestock species.
Development of CNS acting drugs to treat disorders such as Parkinson's and Alzheimer's disease and depression.
See http://www.biopestlab.ucdavis.edu/ for additional information.
Nancy E. Lane, MD
Professor of Medicine and Rheumatology
Director: UC Davis Center for Musculoskeletal Health
Director: Building Interdisciplinary Research Careers in Women's Health (BIRCWH)
(See also: Anesthesia/Pain Management, Epidemiology, Translational Research)
Dr. Lane is translational scientist in musculoskeletal diseases, specifically osteoporosis and osteoarthritis including laboratory base models for over 20 years. Her research has included evaluating how agents to treat osteoporosis affect bone quality, performs proof of concept phase 2 on an NIH funded clinical trial to determine how treatment with PTH could stimulate new bone formation in glucocortioid induced osteoporosis and if an antibody to nerve growth factor could reduce pain in osteoarthritis.
Dr. Lane also has performed epidemiologic studies of osteoarthritis of both the knee and hip in men and women. Dr. Lane has received mentoring awards and currently is the director of UC Davis's K12 program on Building Interdisciplinary Research Careers in Women's Health. Dr. Lane has mentored over 30 trainees in her academic career and has published over 300 articles or chapter.
Currently, Dr. Lane performs preclinical laboratory based studies to determine how bone active agents are used to treat osteoporosis and change bone quality and bone strength; and how a novel hybrid compound, LLP2A-‐Ale, can direct mesenchymal stem cells to the bone surface and augment bone formation in bone disease states including osteoporosis, osteonecrosis and fracture healing.
Mentees are welcome to work on all aspects of this on‐going research.
Please visit Dr. Lane’s website for more information.